BCRP expression in cancer cells confers drug resistance in leukemia, and higher levels are reported in solid tumors from the digestive tract, endometrium, lung, and melanoma, although, contrarily, expression is generally low in breast cancer tumours [54]. This evidence concerns the gene ABCG2 and breast carcinoma.